147 related articles for article (PubMed ID: 10572741)
1. [The effect of the dopamine neuronal reuptake inhibitor GBR 12909 on the dopaminergic neurotransmission parameters in the rat striatum in vivo].
Budygin EA; Kilpatrick M; Gaĭnetdinov RR; Raevskiĭ KS; Wightman RM
Eksp Klin Farmakol; 1999; 62(5):3-6. PubMed ID: 10572741
[TBL] [Abstract][Full Text] [Related]
2. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production.
Shahabi HN; Andersson DR; Nissbrandt H
Synapse; 2008 May; 62(5):379-88. PubMed ID: 18288650
[TBL] [Abstract][Full Text] [Related]
4. Reverse microdialysis of a dopamine uptake inhibitor in the nucleus accumbens of alcohol-preferring rats: effects on dialysate dopamine levels and ethanol intake.
Engleman EA; McBride WJ; Wilber AA; Shaikh SR; Eha RD; Lumeng L; Li TK; Murphy JM
Alcohol Clin Exp Res; 2000 Jun; 24(6):795-801. PubMed ID: 10888067
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity.
Engberg G; Elverfors A; Jonason J; Nissbrandt H
Synapse; 1997 Feb; 25(2):215-26. PubMed ID: 9021902
[TBL] [Abstract][Full Text] [Related]
6. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake.
Budygin EA; Gainetdinov RR; Kilpatrick MR; Rayevsky KS; Männistö PT; Wightman RM
Eur J Pharmacol; 1999 Apr; 370(2):125-31. PubMed ID: 10323260
[TBL] [Abstract][Full Text] [Related]
7. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices.
Szasz BK; Vizi ES; Kiss JP
Neuroscience; 2007 Mar; 145(1):344-9. PubMed ID: 17207584
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats.
Budygin EA; Phillips PE; Robinson DL; Kennedy AP; Gainetdinov RR; Wightman RM
J Pharmacol Exp Ther; 2001 Apr; 297(1):27-34. PubMed ID: 11259524
[TBL] [Abstract][Full Text] [Related]
10. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
[TBL] [Abstract][Full Text] [Related]
11. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
[TBL] [Abstract][Full Text] [Related]
12. Changes in dopamine and acetylcholine in striatum of the awake rat after chronic treatment with a dopamine uptake blocker.
Hernández LF; Segovia G; Mora F
Brain Res Bull; 2006 Feb; 68(6):448-52. PubMed ID: 16459201
[TBL] [Abstract][Full Text] [Related]
13. Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.
Arai A; Tomiyama M; Kannari K; Kimura T; Suzuki C; Watanabe M; Kawarabayashi T; Shen H; Shoji M
Synapse; 2008 Aug; 62(8):632-5. PubMed ID: 18509855
[TBL] [Abstract][Full Text] [Related]
14. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
Miller DW; Abercrombie ED
J Neurochem; 1999 Apr; 72(4):1516-22. PubMed ID: 10098856
[TBL] [Abstract][Full Text] [Related]
15. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
16. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo.
Witten L; Sager T; Thirstrup K; Johansen JL; Larsen DB; Montezinho LP; Mørk A
J Neurosci Res; 2009 May; 87(7):1686-94. PubMed ID: 19156859
[TBL] [Abstract][Full Text] [Related]
17. GBR-12909 effect on dopamine outflow depends on phosphorylation in the caudate nucleus of the rat.
Thümen A; Qadri F; Sarkar R; Moser A
Synapse; 2002 Nov; 46(2):72-8. PubMed ID: 12211084
[TBL] [Abstract][Full Text] [Related]
18. Modification of dopamine release by selective inhibitors of MAO-B.
Finberg JP; Lamensdorf I; Armoni T
Neurobiology (Bp); 2000; 8(2):137-42. PubMed ID: 11061211
[TBL] [Abstract][Full Text] [Related]
19. Cocaine-induced Fos expression in rat striatum is blocked by chloral hydrate or urethane.
Kreuter JD; Mattson BJ; Wang B; You ZB; Hope BT
Neuroscience; 2004; 127(1):233-42. PubMed ID: 15219685
[TBL] [Abstract][Full Text] [Related]
20. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
